Malignant Mesothelioma

This is a serious type of cancer that affects the thin lining around your lungs (pleura) or abdomen (peritoneum). It's caused by exposure to asbestos fibers. The cancer can spread to other parts of the body. It's a difficult cancer to treat.

Condition

What people with Malignant Mesothelioma report

Every report comes from a Lived member, sent anonymously.

Have you tried Pemetrexed for Malignant Mesothelioma?

NameHow it went

About Malignant Mesothelioma

What It Is

Malignant mesothelioma is a cancer of the mesothelium, the thin layer of tissue that lines the chest, the abdomen and the sac around the heart. Today it is usually just called mesothelioma. It is rare, with about 3,000 new cases a year in the United States, and it is serious: because of where it starts and how it spreads along the lining, it is hard to remove completely. More than 8 in 10 cases start in the lining of the chest (pleural mesothelioma), where the cancer can cause fluid to collect around the lung and bring on breathlessness, cough and pain in the side of the chest or lower back. Most of the rest start in the lining of the abdomen (peritoneal mesothelioma), which can cause belly swelling, pain, nausea and loss of appetite. Mesothelioma around the heart or the testicles is very rare. Because early symptoms resemble common problems, the disease is often advanced by the time it is found.

Causes & Risk Factors

Asbestos is by far the main cause. Asbestos is a group of natural minerals made of tiny fibers, once widely used in insulation and building materials. Inhaled fibers can lodge in the chest lining and damage its cells over many years; swallowed fibers can reach the lining of the abdomen. Most cases trace back to heavy exposure at work, for example in shipyards, construction, insulation, plumbing, mining, and railroad or automotive trades. Family members have also been affected by fibers carried home on work clothes. The delay is long: usually 20 to 50 years pass between first exposure and diagnosis, and the risk does not fade after exposure stops. That is why mesothelioma is mostly diagnosed in older adults (about age 70 on average for the chest form) and is more common in men. Still, most people exposed to asbestos, even heavily, never develop it. Other factors include past high-dose radiation to the chest or abdomen and, rarely, an inherited change in the BAP1 gene that raises the risk of mesothelioma and some other cancers. Some people have no known exposure at all. Asbestos materials that are intact and undisturbed generally do not pose a risk; the danger comes when they are damaged or removed without proper precautions.

How It's Diagnosed

Evaluation starts with symptoms, a physical exam and a detailed work history, because past asbestos exposure is an important clue. A chest x-ray or CT scan may show thickening of the lining or fluid around the lung; PET scans and MRI help show how far the cancer extends. Blood markers such as soluble mesothelin-related peptides can be raised, but they cannot diagnose mesothelioma on their own. A biopsy is usually needed to confirm it. Fluid drained from the chest or belly can be tested, but it often does not give a clear answer, so many people need a tissue sample, commonly taken through a small camera in the chest (thoracoscopy) or abdomen (laparoscopy). Under the microscope, mesothelioma can look like lung cancer or, in the abdomen, ovarian cancer, so pathologists use special stains to tell them apart. Because the diagnosis is difficult, a review by an experienced pathologist or a second opinion is common. The report also names the cell subtype. Epithelioid mesothelioma, about 6 in 10 cases, tends to have a better outlook and is more likely to benefit from surgery than sarcomatoid or mixed (biphasic) types. Together with the stage and breathing tests, the subtype shapes which treatments make sense.

Treatment Options

Treatment is usually planned by a team that may include a thoracic surgeon, medical oncologist and radiation oncologist. For most people the goal is to control the cancer, extend life and ease symptoms, because a cure is rarely possible. For pleural mesothelioma that cannot be removed with surgery, immunotherapy is now a standard first treatment. Nivolumab (Opdivo) and ipilimumab (Yervoy) are immune checkpoint inhibitors, drugs that release brakes on the immune system so it can attack the cancer. In the main trial, this combination helped people live longer than chemotherapy (2-year survival of about 41% versus 27%), and a small group were still alive at 5 years. Another option combines pembrolizumab (Keytruda), a related immunotherapy drug, with chemotherapy using pemetrexed and a platinum drug (cisplatin or carboplatin). Chemotherapy alone, sometimes with bevacizumab, a drug that blocks blood vessel growth to the tumor, remains an option. The main trade-off with immunotherapy is that the immune system can also attack healthy organs, such as the lungs, bowel, liver or hormone glands; this is less common than ordinary chemotherapy side effects but can be serious. Surgery suits a minority of people: generally those in good health with epithelioid disease that has not spread widely. Operations such as pleurectomy/decortication (removing the lining of the lung and chest wall) are major procedures, should be done at a center experienced with mesothelioma and are usually combined with drug treatment. Even then, some cancer cells are usually left behind. For peritoneal mesothelioma, surgery to remove visible tumor may be followed by heated chemotherapy washed through the abdomen (HIPEC). Relieving symptoms is a central part of care at every stage. Draining fluid from around the lung, sealing the space so fluid stops returning (pleurodesis) or placing a small long-term drainage tube can ease breathlessness. Radiation can also relieve symptoms such as pain. Clinical trials are an important option given the limits of current treatments.

What to Expect

Mesothelioma is usually a serious, life-limiting cancer, though the course varies widely. Among people diagnosed with pleural mesothelioma between 2015 and 2021, about 15% overall were alive 5 years later, ranging from about 23% when the cancer was confined to the lining to about 11% when it had spread to distant sites. These figures predate some newer treatments and cannot predict one person's outcome; the cell subtype, overall health and response to treatment all matter, and epithelioid disease tends to have a better outlook. Daily life is often shaped by breathlessness, chest pain, tiredness and weight loss, and by the treatment schedule itself, with infusions every few weeks and regular scans to check whether treatment is working. Fluid around the lung or in the belly can return and need draining again. A palliative care team, which specializes in symptom relief and quality of life alongside cancer treatment, can help with pain, breathing and planning. Early conversations about goals, finances and care preferences help families prepare.

When to Seek Help

If you have ever worked with or lived around asbestos, tell your doctor. There is no recommended screening test for people with past exposure, so knowing the symptoms matters. See a clinician promptly for breathlessness that is new or getting worse, ongoing chest or lower back pain, a persistent cough, belly swelling or pain, or weight loss without trying, especially with a history of asbestos exposure. During treatment, contact your care team right away about any new or worsening symptom, particularly on immunotherapy, since immune side effects can start during treatment or after it ends. Examples include new cough or shortness of breath, diarrhea, yellowing of the skin or eyes, a rash, or unusual tiredness. Breathlessness that returns after fluid has been drained also deserves a prompt call, as the fluid may need draining again.

Questions to Ask Your Doctor

  1. 1.What type and stage of mesothelioma do I have, and has an experienced pathologist confirmed it?
  2. 2.Is surgery a realistic option for me, and if not, how do immunotherapy and chemotherapy compare for my situation?
  3. 3.What side effects should I watch for, and how quickly should I report them?
  4. 4.How will we manage fluid buildup, pain and breathlessness, and when should palliative care get involved?
  5. 5.Are there clinical trials or specialist mesothelioma centers I should consider, and should I have genetic testing?

Last reviewed • Oct 2026

Educational content, not medical advice.